Exosens shares have soared on the stock market (+53%!) since our last update on the French specialist in military night vision. Exosens was on the verge of securing a major contract with Germany for night vision goggles. This week, the defense gem secured a record contract with an actor in autonomous air defense systems for the sale of digital imaging solutions for interceptor drones.
In just 6 months, Exosens has built up an order book of over 10,000 thermal cameras for autonomous platforms (air, land, sea), with estimated revenue exceeding 15 million euros. This positioning is strengthened by “the rise in budgets allocated to anti-drone systems, the sovereign imperative of ITAR-free solutions, and the key role of thermal sensors in any embedded AI architecture,” notes broker TP Icap, highlighting that Exosens is in a strong position in a market where demand is increasingly recurrent (purchases repeated by clients, often in growing volumes).
Exosens benefits from limited competitive pressure
This major contract “illustrates the relevance of the Xenics product (ultra-compact thermal micro-cameras) for the rapidly growing segment of interceptor drones. The mid-range positioning of Exosens makes sense, as the low-end does not allow for profitable high-performance sensors, and the high-end is dominated by vertically integrated players,” argues TP Icap, also emphasizing that the ITAR-free status reinforces barriers to entry and remains an asset for non-American programs, with American leader Teledyne FLIR having limited reach compared to Exosens in Europe.
Exosens has been able to ramp up quickly without relying on heavy industrial investments. Exosens “is able to absorb high volumes in short periods, adapting to evolving client specifications, a factor in a context of strong demand acceleration,” notes the broker. The challenge is to target clients with strong traction in their markets, capable of securing large contracts with defense ministries (Europe, the United States, and other areas).
Exosens will be “a direct beneficiary of progress in embedded AI for drones and autonomous systems,” potential on the stock market?
The increasing autonomy of drones relies on efficient vision systems for detection and targeting, like those sold by Exosens. Sensor suppliers like Exosens are positioned as “direct beneficiaries of every progress in embedded AI for drones and autonomous systems,” according to TP Icap. Drones could quickly become a significant additional growth driver for Exosens’ detection and imaging division, according to Stifel, who finds the contract secured by Exosens encouraging.
The broker has significantly raised the estimated fair price of Exosens shares, which still seem to have medium-term appreciation potential on the stock market. What medium-term target price can be set for Exosens shares, according to financial analysis? And is it still a good time to buy Exosens shares, according to technical analysis (graphical and mathematical analysis of stock price movements)? Find out in Momentum, the daily premium investment newsletter from Capital based on technical and financial analysis.
Amid the defense sector’s boom since the outbreak of the war in Ukraine in 2022 and Germany and the European Union’s announcements of mega-military investments in 2025, Exosens’ share price has nearly tripled since our initial buy recommendations on this French defense gem, which went public in June 2024. And the stock selection in Momentum has progressed much faster than the CAC 40 since 2021. By opting for an annual subscription, you can get 5 months free. To take advantage, simply click on the link provided.
